Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Taking too many vitamin and mineral supplements can cause serious health problems.

Diabetes often causes various skin problems and complications.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Targeting EGFR may help reduce hair loss from chemotherapy.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Certain zinc transporters are essential for healthy skin and managing zinc in the body could help treat skin problems.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Moderately high prolactin levels do not cause hair loss in women.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.